Ultrasound Guided Intermediate Cervical Plexus Block for Congenital Muscular Torticollis

Ajou University School of Medicine

Status and phase

Completed

Phase 4

Conditions

Congenital Muscular Torticollis

Treatments

Drug: Fentanyl

Drug: Ibuprofen

Other: intermediate cervical plexus block

Study type

Interventional

Funder types

Other

Identifiers

NCT02651311

MED-DRU-15-002

Details and patient eligibility

About

Congenital Muscular Torticollis (CMT) is a postural deformity of head and neck detected at birth or shortly after birth, primarily resulting from unilateral shortening of Sternocleidomastoid Muscle (SCM). Surgery could be chosen for the treatment for some children, which is accompanied by moderate pain and discomfort. The investigators focused the effectiveness of intermediates cervical plexus block because the dermatome of sensory of cervical plexus block is correlated to that of torticollis. So the effect of analgesia could decrease the use of analgesics.

Enrollment

32 patients

Sex

All

Ages

1 to 7 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

ASA I-II
Undergoing general anesthesia for unipolar sternocleidomastoid release in patient with congenital muscular torticollis

Exclusion criteria

coagulation disorder
kidney or liver disease
allergy to local anesthetics

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

32 participants in 2 patient groups, including a placebo group

Block

Experimental group

Description:

ultrasound guided intermediate cervical plexus block with 0.25% ropivacaine 0.2 ml/kg. Fentanyl in postanesthesia care unit(PACU), Ibuprofen in ward when pain scale (FLACC) is equal to or more than 4.

Treatment:

Other: intermediate cervical plexus block

Drug: Ibuprofen

Drug: Fentanyl

No block

Placebo Comparator group

Description:

Fentanyl in PACU, Ibuprofen in ward when pain scale (FLACC) is equal to or more than 4.

Treatment:

Drug: Ibuprofen

Drug: Fentanyl